The novel treatment of tirzepatide peptide represents a significant breakthrough in the management of the condition. Distinct from existing medications, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) – leading to enhanced sugar management and anticipated weight loss… Read More